Health care startups in Suzhou, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Kossel Medical | Suzhou | Series C | $59.5M | 2026-09-01 |
| HemaCell | Suzhou | Series B | $14.8M | 2026-06-02 |
| iCamumo | Suzhou | Series A | $14.4M | 2026-03-09 |
| AccuPulse | Suzhou | Series B | $14.5M | 2026-03-13 |
| Yuce Biotechnology | Suzhou | Series B | $7.4M | 2026-08-31 |
| CureGenetics | Suzhou | Series B | $9.0M | 2024-03-28 |
| Micro-Ray Technology | Suzhou | Seed | $14.4M | 2026-01-23 |
| Atom Bioscience & Pharmaceutical | Suzhou | Series D | $82.1M | 2023-10-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 214 health care startups in Suzhou, China have raised $3.3B in total.
- 49 of them closed their most recent round in the last 12 months, $556.7M combined.
- The largest of those rounds is Kossel Medical's $59.5M Series C, dated September 2026.
- Oriza Holdings is an investor in 5 of them, more than any other fund.
- Biotech is the most common other sector, with 98 companies (46%).
- 43% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
13 of 214| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Kossel Medical | Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. | Health care | Series C | $59.5M | 2026-09-01 | $103.0M | Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 | 501 to 1,000 | 2013 |
| Yuce Biotechnology | Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. | Biotech | Series B | $7.4M | 2026-08-31 | $22.4M | Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 | 101 to 250 | 2019 |
| Haimai Medical | Haimai Medical develops tissue engineering and regenerative medicine technologies. | Health care | Series A | $14.3M | 2026-06-12 | $14.3M | IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 | 51 to 100 | 2021 |
| HemaCell | HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. | Biotech | Series B | $14.8M | 2026-06-02 | $62.0M | Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation | 1 to 10 | 2021 |
| AccuPulse | AccuPulse develops pulsed electric field ablation generators and catheters. | Health care | Series B | $14.5M | 2026-03-13 | $72.5M | BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 | 11 to 50 | 2020 |
| iCamumo | iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. | Biotech | Series A | $14.4M | 2026-03-09 | $75.2M | Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment | 51 to 100 | 2021 |
| Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| Junji Gene | Junji Gene provides intelligent gene synthesis labs and localizes raw materials for diagnostic kits. | Artificial intelligence | Series A | $14.2M | 2025-12-15 | $14.2M | Dongfang Jiafu | 51 to 100 | 2021 |
| Kunshi Biotechnology | Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. | Biotech | Series A | $7.0M | 2025-11-20 | $7.0M | Deshi Capital | 51 to 100 | 2021 |
| DK MedTech | DK MedTech manufactures vascular interventional medical device products. | Health care | Series E | $24.5M | 2024-06-21 | $36.2M | Qiming Venture Partners, Legend Capital, Oriza Seed Capital (Oriza Yuandian) +1 | 251 to 500 | 2015 |
| Yidao Biotechnology | Yidao Biotechnology researches and develops vaccines and biomedical products. | Biotech | Series D | $25.2M | 2024-05-09 | Qiming Venture Partners, Northern Light Venture Capital | 2017 | ||
| CureGenetics | CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. | Biotech | Series B | $9.0M | 2024-03-28 | Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 | 51 to 100 | 2016 | |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company. | Biotech | Series D | $82.1M | 2023-10-16 | Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 | 11 to 50 | 2012 |
Table 1. Health care startups in Suzhou, China: the 13 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 214.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kossel Medical | Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. | Health care | Series C | $59.5M | 2026-09-01 | $103.0M | Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 | 501 to 1,000 | 2013 |
| 2 | HemaCell | HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. | Biotech | Series B | $14.8M | 2026-06-02 | $62.0M | Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation | 1 to 10 | 2021 |
| 3 | AccuPulse | AccuPulse develops pulsed electric field ablation generators and catheters. | Health care | Series B | $14.5M | 2026-03-13 | $72.5M | BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 | 11 to 50 | 2020 |
| 4 | iCamumo | iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. | Biotech | Series A | $14.4M | 2026-03-09 | $75.2M | Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment | 51 to 100 | 2021 |
| 5 | Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| 6 | Haimai Medical | Haimai Medical develops tissue engineering and regenerative medicine technologies. | Health care | Series A | $14.3M | 2026-06-12 | $14.3M | IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 | 51 to 100 | 2021 |
| 7 | Junji Gene | Junji Gene provides intelligent gene synthesis labs and localizes raw materials for diagnostic kits. | Artificial intelligence | Series A | $14.2M | 2025-12-15 | $14.2M | Dongfang Jiafu | 51 to 100 | 2021 |
| 8 | Yuce Biotechnology | Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. | Biotech | Series B | $7.4M | 2026-08-31 | $22.4M | Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 | 101 to 250 | 2019 |
| 9 | Kunshi Biotechnology | Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. | Biotech | Series A | $7.0M | 2025-11-20 | $7.0M | Deshi Capital | 51 to 100 | 2021 |
Table 2. Health care startups in Suzhou, China: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Oriza Holdings | Venture capital firm | Suzhou, China | 5 | 2% | ||
| 2 | Puhua Capital | Venture capital firm | Hangzhou, China | 3 | 1% | 1 | Yuce Biotechnology |
| 3 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 3 | 1% | ||
| 4 | Ming Bioventures | Venture capital firm | Suzhou, China | 2 | 1% | 1 | Kossel Medical |
| 5 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | Kossel Medical |
| 6 | Northern Light Venture Capital | Venture capital firm | Beijing, China | 2 | 1% | 1 | HemaCell |
| 7 | BioVenture | Venture capital firm | Suzhou, China | 2 | 1% | 1 | AccuPulse |
| 8 | Shanghai Biomedical Industrial Equity Investment Fund | Venture capital firm | Huangpu, China | 2 | 1% | 2 | Haimai Medical, AccuPulse |
| 9 | Zhengxuan Investment | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | Yuce Biotechnology |
| 10 | Oriza Seed Capital (Oriza Yuandian) | Venture capital firm | Suzhou, China | 2 | 1% | ||
| 11 | Pan-Lin Capital | Venture capital firm | Shanghai, China | 2 | 1% | ||
| 12 | SND Ventures Group | Private equity firm | Suzhou, China | 2 | 1% | ||
| 13 | Suzhou International Development Venture Capital | Venture capital firm | Suzhou, China | 1 | 0% | 1 | Kossel Medical |
| 14 | Yueyin Venture Capital | Venture capital firm | Beijing, China | 1 | 0% | 1 | Kossel Medical |
| 15 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 1 | 0% | 1 | HemaCell |
Table 3. Health care startups in Suzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 98 | 46% | $1.9B |
| Software | 18 | 8% | $133.1M |
| Hardware | 16 | 7% | $127.4M |
| Artificial intelligence | 12 | 6% | $32.6M |
| Commerce | 3 | 1% | $10.4M |
| Education | 1 | 0% | $455K |
| Fintech | 1 | 0% | $625K |
Table 4. Health care startups in Suzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Suzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 2% | |
| September 2026 | 3 | 6% | $59.5M |
| August 2026 | 4 | 8% | $81.9M |
| July 2026 | 2 | 4% | $29.6M |
| June 2026 | 2 | 4% | $29.1M |
| May 2026 | 5 | 10% | $119.4M |
| April 2026 | 1 | 2% | $29.3M |
| March 2026 | 8 | 16% | $64.2M |
| February 2026 | 2 | 4% | $50.6M |
| January 2026 | 12 | 24% | $71.8M |
| December 2025 | 8 | 16% | $14.2M |
| November 2025 | 1 | 2% | $7.0M |
Table 6. Health care startups in Suzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 40 | 19% | $535.4M |
| 2025 | 36 | 17% | $205.3M |
| 2024 | 34 | 16% | $192.5M |
| 2023 | 22 | 10% | $330.7M |
| 2022 | 23 | 11% | $531.4M |
| 2021 | 13 | 6% | $684.6M |
Table 7. Health care startups in Suzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 23 | 11% |
| 2020 to 2022 | 67 | 32% |
| 2015 to 2019 | 68 | 33% |
| 2010 to 2014 | 35 | 17% |
| Before 2010 | 14 | 7% |
Table 8. Health care startups in Suzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 16 | 10% |
| 11 to 50 | 71 | 43% |
| 51 to 100 | 37 | 22% |
| 101 to 250 | 28 | 17% |
| 251 to 500 | 9 | 5% |
| 501 to 1,000 | 3 | 2% |
| 1,001 to 5,000 | 1 | 1% |
Table 9. Health care startups in Suzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Suzhou, China. On 16 November 2026 that is 214 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 13 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 214 rows: 100 have no round amount, 0 no city and 83 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Suzhou, China are on the list?
- 214, in the file dated 16 November 2026. 49 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 214 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.